What does ITP stand for?

Idiopathic Thrombocytopenic Purpura

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Inconvenient Truth of the Day (blog) Interesting Thing of the Day It Takes One To Know One IT Outsourcing and Utility Services (information technology) In The Out World (band) In Their Own Words Independent Towers of Washington (vehicle towing; Olympia, WA) International Tropospheric Ozone Year i tym podobne (Polish: and the like) Identity Theft Protection (software)		IML (Information Markup Language) Transport Protocol (for Simputer) Immune Thrombocytopenic Purpura (blood disorder) Implementation Training Package Improved Transmission Performance In This Picture In-Tank Precipitation (nuclear waste) In-Target Probe Incidental Take Permit Increment Training Plan Independent Transmission Provider (electric power)

Samples in periodicals archive:

Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines.

Management of brucella-induced thrombocytopenic purpura/Brusellaya ...

have chronic idiopathic thrombocytopenic purpura, an immune system disorder that causes the body to destroy its own platelets, components of blood that help with clotting.

FDA says Glaxo drug fails to control bleeding

have chronic idiopathic thrombocytopenic purpura, an immune system disorder that causes the body to destroy its own platelets, components of blood that help with clotting.

FDA says Glaxo drug fails to control bleeding

Julia A, Araguas C, Rossello J, et al: Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura (ITP).

Rituximab: an anti-CD20 antibody for the treatment of chronic ...

is a biotechnology company engaged in the development of a new class of drugs for the treatment of rheumatoid arthritis, idiopathic thrombocytopenic purpura and a host of other autoimmune disorders.

Protalex, Inc. to Present at Rodman & Renshaw 10th Annual Healthcare ...

The drug is aimed at treating chronic short-term idiopathic thrombocytopenic purpura, a condition that causes increased risk of bruising and bleeding.

Glaxo, Ligand drug gets negative FDA assessment

Thrombopoiesis stimulating agents are under evaluation for treatment of idiopathic thrombocytopenic purpura (ITP) and for prevention of severe thrombocytopenia induced by chemotherapy.

A Competitor Analysis of Thrombopoiesis-Stimulating Agents (TPO): ...

Food and Drug Administration has extended the priority review period for GlaxoSmithKline's (GSK) New Drug Application (NDA) for PROMACTA[R] (eltrombopag) for the short-term treatment of chronic idiopathic thrombocytopenic purpura (ITP).

Ligand Partner GlaxoSmithKline Receives FDA Extended Priority Review ...